Related Experiment Video

Updated: Jul 11, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse

Hajime Hosoi1, T Iehara, K Tsuchiya

  • 1Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. hhosai@koto.kpu-m.ac.jp

Journal of Pediatric Surgery
|October 10, 2007
PubMed

Insights

Long-term survival was achieved in a pediatric patient with malignant rhabdoid tumor (MRT) through aggressive treatment. This included complete surgical resection, intensive chemotherapy, and radiotherapy, establishing a strategy for this aggressive childhood cancer.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology

Background:

  • Malignant rhabdoid tumor (MRT) is a rare and aggressive pediatric cancer with a poor prognosis, particularly in infants.
  • Early diagnosis and effective treatment strategies are crucial for improving outcomes in children with MRT.

Observation:

  • A 5-month-old boy diagnosed with chest wall MRT experienced a local recurrence after initial treatment.
  • The patient underwent a second complete tumor resection followed by chemotherapy and local radiotherapy.

Findings:

  • The patient achieved a second complete remission and has remained disease-free for 5 years.
  • The child is now 7.5 years old and in good health, demonstrating long-term survival post-treatment.

Implications:

  • This case highlights the importance of complete surgical resection for localized MRT.
  • Intensive multiagent chemotherapy and radiotherapy are vital for managing minimal disseminated disease and local control.
  • A multimodal treatment approach combining surgery, chemotherapy, and radiotherapy can lead to successful long-term outcomes for pediatric MRT.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: